Yan Tung Rachel Tam

Dr. Yan Tung Rachel Tam


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
CCChristopher Chan
Christopher Chan
MCMichael J. Coffey
Michael J. Coffey
CMCaitlin Murphy
Caitlin Murphy
IMIsabelle McKay
Isabelle McKay
JAJumaana Abdu
Jumaana Abdu
KOKeith Ooi
Keith Ooi
Cystic fibrosis (CF) patients experience higher risks of colorectal cancer but the pathogenesis is unclear. In the general population, polyketide synthase-positive (pks+) E. coli is implicated in intestinal carcinogenesis via the production of colibactin; however, the relevance in CF is unknown. In this study, we investigate pks+E. coli prevalence in CF and potential associations between pks+E. coli, gastrointestinal inflammation, and microbiome dynamics with fecal calprotectin and 16SrRNA gene taxonomic data. Cross-sectional analysis demonstrated no difference in pks+E. coli carriage between CF patients and healthy controls, 21/55 (38%) vs. 26/55 (47%), p = 0.32. Pks+E. coli was not associated with significant differences in mean (SD) calprotectin concentration (124 (154) vs. 158 (268) mg/kg; p = 0.60), microbial richness (159 (76.5) vs. 147 (70.4); p = 0.50) or Shannon diversity index (2.78 (0.77) vs. 2.65 (0.74); p = 0.50) in CF. Additionally, there was no association with exocrine pancreatic status (p = 0.2) or overall antibiotic use (p = 0.6). Longitudinally, CF subjects demonstrated intra-individual variation in pks+E. coli presence but no significant difference in overall prevalence. Future investigation into the effects of repeat exposure on risk profile and analysis of older CF cohorts is necessary to identify if associations with colorectal cancer exist.

13 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
CCChristopher Chan
Christopher Chan
MCMichael J. Coffey
Michael J. Coffey
CMCaitlin Murphy
Caitlin Murphy
IMIsabelle McKay
Isabelle McKay
JAJumaana Abdu
Jumaana Abdu
KOKeith Ooi
Keith Ooi
Cystic fibrosis (CF) patients experience higher risks of colorectal cancer, but pathogenesis is unclear. In the general population, polyketide synthase-positive (pks+) E. coli is impli-cated in intestinal carcinogenesis via production of colibactin, however relevance in CF is unknown. We investigated pks+ E. coli prevalence in CF at baseline and longitudinally, performing PCR on stool DNA extracts. Potential associations between pks+ E. coli and gastrointestinal inflammation or microbiome dynamics were analysed using faecal calprotectin and 16SrRNA gene taxonomic data. At baseline, no difference in pks+ E. coli carriage was identified between CF and healthy controls, 21/55(38%) vs 26/55(47%), p=0.32. Pks+ E. coli was not associated with significant differences in mean (SD) calpro-tectin concentration (124(154) vs 158(268) mg/kg; p=0.60), microbial richness (159(76.5) vs 147(70.4); p=0.50) or Shannon diversity index (2.78(0.77) vs 2.65(0.74); p=0.50) in CF. Lon-gitudinally, subjects demonstrated intra-individual variation in pks+ E. coli presence, however no significant difference in overall prevalence was observed. Thus, intesti-nal pks+ E. coli prevalence was not different between CF and healthy controls, nor associ-ated with differences in gut microbial profile or inflammation. Investigating effects of re-peat exposure on risk profile and analysis of older CF cohorts is necessary to identify if associations with colorectal cancer exist.